Western blot shows recombinant Zika Virus (H/PF/2013) Envelope (rvZIKV-E3). PVDF membrane was probed with 1 µg/mL of Mouse Anti-Viral Zika Virus (H/PF/2013) Envelope Monoclonal Antibody (Catalog # MAB10009) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for Zika Virus (H/PF/2013) Envelope at approximately 10 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Applications for Viral Zika Virus (H/PF/2013) Envelope Antibody

Application

Recommended Usage

ELISA

This antibody functions as an ELISA capture antibody when paired with Mouse Anti-Viral Zika Virus (H/PF/2013) Envelope Monoclonal Antibody (Catalog # MAB100091).

This product is intended for assay development on various assay platforms requiring antibody pairs.

Western Blot

1 µg/mL
Sample: Recombinant Zika Virus (H/PF/2013) Envelope

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Zika Virus (H/PF/2013) Envelope

Zika Virus non-structural protein 1 (ZIKV NS1) is an approximately 48 kDa viral glycoprotein (1). Zika Virus is a mosquito-borne flavivirus and has been implicated an association with neonatal microcephaly and neurological disorders such as Guillain-Barré syndrome (2). ZIKV strain H/PF/2013 was isolated from human host. ZIKV NS1 is a multifunctional virulence factor. The glycosylated NS1 exists as a membrane-associated dimer after translocation into the endoplasmic reticulum lumen, where it is essential for viral genome replication (1, 2). Infected cells secrete NS1 as a lipoprotein, which is involved in immune evasion and pathogenesis via interaction with components of the innate and adaptive immune systems (1, 2). Mature ZIKV NS1 contains 352 amino acids (aa) and has a hexameric conformation consisting of three dimers to form a symmetric barrel shape (1). It has high structural similarity to other flavivirus NS1 proteins, such as DENV and WNV (2, 3). Mature NS1 of ZIKV strain H/PF/2013 shares 98% aa sequence identity with NS1 of ZIKV strain MR 766 that was isolated from monkey host.

References

Song, H. et al. (2016) Nat. Struct. and Mol. Biol. 23:456.
Brown, WC. et al. (2016) Nat. Struct. and Mol. Biol. 23: 865.
Baronti, C. et al. (2014) Genome Announc. 2: e00500

Long Name

Zika Virus Polyprotein

Alternate Names

ZIKV-E, ZIKV-Env, ZIKV_E

Additional Zika Virus (H/PF/2013) Envelope Products

Product Documents for Viral Zika Virus (H/PF/2013) Envelope Antibody

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for Viral Zika Virus (H/PF/2013) Envelope Antibody

For research use only

Citations
Reviews

Viral Zika Virus (H/PF/2013) Envelope Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB10009

Key Product Details

Species Reactivity

Validated:

Cited:

Applications

Validated:

Cited:

Label

Antibody Source

View all Zika Virus (H/PF/2013) Envelope Antibodies »

Product Specifications

Immunogen

Specificity

Clonality

Host

Isotype

Scientific Data Images for Viral Zika Virus (H/PF/2013) Envelope Antibody

Detection of Zika Virus (H/PF/2013) Envelope by Western Blot.